ghk-cu peptide legal status Research Guide: Copper Overview and Laboratory Research GHK-CU 100 mg | 99%+

Availability: In stock Research Applications Common Use FOXO4-DRI is commonly used in research to study cellular senescence and the selective elimination of aged cells

However, according to the National Institutes of Health, upwards of 15% of people are deficient in vitamin B12and some studies indicate that number may be higher

Unlike pharmacological interventions that target single receptors or pathways, GHK-Cus multi-gene modulation touches many of the hallmarks of aging simultaneously: Genomic instability (DNA repair gene upregulation) Epigenetic alterations (chromatin remodeling via altered transcription factor activity) Loss of proteostasis (chaperone and proteasome pathway modulation) Cellular senescence (anti-apoptotic and anti-senescence gene networks) Altered intercellular communication (anti-inflammatory cytokine modulation) This positions GHK-Cu within what researchers increasingly call multi-hallmark peptide therapy a conceptual framework that prioritizes compounds acting across multiple aging mechanisms simultaneously

Ingredients Purified water, ethylhexyl palmitate, squalane, cetyl alcohol, dimethyl MEA, algae extract, pullulan, stearic acid, glycerol stearate, PEG-100 stearate, Copper Tripeptide-1 (GHK-Cu), phenoxyethanol, PPG 2 myristyl ether propionate, C10-30 cholesterol/lanosterol esters, polysorbate 80, allantoin, aloe barbadensis (aloe vera) gel, glycine, leucine, tocophersolan (Vitamin E), mixed (alpha, beta, gamma, delta) tocotrienols, mixed (alpha, beta, gamma, delta) tocopherols, ubiquinone (CoQ-10), and xanthophyll (lutein)

paired t test), as well as a trend for improvement in the categories of pressure pain and pain attacks ( p = 0.08 and p = 0.09) in the ARA 290 group, but not in the placebo group

Explore treatments Programs & RX Medical programs GLP-1 weight loss, hormones, peptides, and prescription refills supervised by Ryan Kent, FNP-BC with telehealth built in